Stocks making the biggest moves premarket: IMAX, Merck, Estee Lauder & more

Premarket movers were dominated by strong earnings beats, raised guidance, and strategic corporate actions. Workday jumped more than 8% on stronger-than-expected results and a higher full-year margin outlook, Zoom rose 7% after beating earnings and revenue and adding $1 billion to buybacks, and Ross Stores gained 4.5% on a quarterly beat and improved guidance. M&A/speculation also lifted Estee Lauder (+10%) and IMAX (+14%), while Futu plunged 36% after China intensified cross-border securities trading crackdowns.

Analysis

This tape is less about one-off beats and more about balance-sheet optionality reasserting itself. The cleanest signal is that companies with credible buyback capacity and improving margin durability are being rewarded more than pure top-line stories, which is why the market is favoring software and consumer names with self-help levers over lower-quality cyclical exposure. That dynamic should continue to compress dispersion within large-cap growth while widening it in retail and specialty consumer.

The most interesting second-order read is on governance and capital allocation. Management changes plus margin guide raises in software suggest investors are willing to pay for operational control when macro visibility is poor, while the sale chatter in media-exposure assets implies strategic buyers still see scarcity value in differentiated content platforms. In contrast, the China crackdown is a reminder that brokerages with cross-border flow dependence can re-rate violently when regulatory regimes shift; that risk is not idiosyncratic and may bleed into adjacent wealth-tech and offshore access names over the next several weeks.

For the consumer pocket, stronger retailer prints point to resilient lower-income demand, but the market is already rewarding proof rather than promise. That makes the upside in names that merely met expectations less attractive than in those with either a path to accretive buybacks or a clear catalyst into a known release window. Meanwhile, the funding win for critical minerals is a policy signal: strategically relevant resource projects now have quasi-defense value, which could bring in non-commercial capital and reduce financing risk premia across the antimony and specialty mining space.

The contrarian issue is that several of these moves look front-loaded relative to fundamentals. The market may be overpaying for “good enough” quarters in software and retail while underpricing how quickly China can expand enforcement to keep pressure on cross-border trading volumes. The best asymmetric setups are still the ones where policy, not just earnings, changes the earnings power of the business.

Key Decisions for Investors

• Long WDAY on pullbacks over the next 1-2 weeks; pair against lower-quality software peers with weaker margin discipline. Risk/reward favors WDAY if the market starts assigning a higher multiple to operating leverage and CEO continuity.
• Short FUTU or buy put spreads expiring in 1-3 months; the move is regulation-driven and can persist beyond the initial headline. Best entry is on any relief bounce, since enforcement risk can cascade to other offshore brokerage proxies.
• Long PPTA for a 3-6 month policy trade; the financing de-risks project execution and creates rerating potential as a strategic-minerals beneficiary. Use a trailing stop on any sign of permitting or loan-condition delay.
• Trade IMAX with options rather than stock: buy 1-2 month call spreads or a small long if sale speculation remains active, but treat as event-driven and fade any extension beyond takeover premium expectations.
• Prefer ZM over DECK/BJ for near-term momentum exposure; ZM has both earnings quality and capital return support, while DECK and BJ look more like confirmation trades and are likely to mean-revert faster.